FCA Health Innovations III QP, LP
New Filing
CIK: 0002134121·Pooled Investment Fund·DELAWARE·Filed: May 15, 2026
Total Offering
$175,000,000
Amount Sold
$49,875,000
Investors
85
First Sale
Apr 30, 2026
Offering Details
- Type
- Equity, Pooled Investment Fund
- Exemptions
- Rule 506(b), Section 3(c), Section 3(c)(7)
- Entity Type
- Limited Partnership
- Year Incorporated
- 2025
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Whitney H. Kalb | |
| Andrew J. Bouldin | |
| Charles W. Johnson | |
| Matthew A. King | |
| . FCA Health Innovations III SLP, LLC | |
| . FCA Health Innovations III GP, LLC |
Company
SEC Filing
0002134121-26-000001
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free